PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma

Xiaoyan Si; Xiaotong Zhang; Hanping Wang; Mengzhao Wang; Li Zhang

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma

【24h】

PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma

机译：PUB125 Nimotuzumab与化疗结合化疗的临床观察作为晚期肺鳞状细胞癌的第一线疗法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共1页
作者
Xiaoyan Si; Xiaotong Zhang; Hanping Wang; Mengzhao Wang; Li Zhang;
展开▼
作者单位

Respiratory Medicine Peking Union Medical College Hospital;

Respiratory Medicine Peking Union Medical College Hospital;

Respiratory Medicine Peking Union Medical College Hospital;

Respiratory Medicine Peking Union Medical College Hospital;

Respiratory Medicine Peking Union Medical College Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma [J] . Xiaoyan Si, Xiaotong Zhang, Hanping Wang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB125 Nimotuzumab与化疗结合化疗的临床观察作为晚期肺鳞状细胞癌的第一线疗法
2. PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma [J] . Xiaoyan Si, Xiaotong Zhang, Hanping Wang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：PUB125 Nimotuzumab与化疗结合化疗的临床观察作为晚期肺鳞状细胞癌的第一线疗法
3. Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma [J] . Xiaoyan Si, Shafei Wu, Hanping Wang, Thoracic cancer. . 2018,第8期

机译：尼妥珠单抗联合化学疗法作为晚期肺鳞癌的一线治疗
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Benzyl Isothiocyanate as an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma. [D] . Wolf, Mary Allison. 2014

机译：异硫氰酸苄酯作为头颈鳞状细胞癌的辅助化疗选择。
6. Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma [O] . Xiaoyan Si, Shafei Wu, Hanping Wang, 2018

机译：尼妥珠单抗联合化学疗法作为晚期肺鳞癌的一线治疗
7. Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma [O] . Xiaoyan Si, Shafei Wu, Hanping Wang, 2018

机译：Nimotuzumab结合化疗作为晚期肺鳞状细胞癌的一线治疗

PUB125 Clinical Observation of Nimotuzumab Combined with Chemotherapy as First Line Therapy for Advanced Lung Squamous Cell Carcinoma

著录项

相似文献

相关主题

期刊订阅